MONSENSO A/S Company Announcement No. 15-2024
“This message includes inside information”
Monsenso A/S announces change of Certified Adviser to
The change is being made to obtain broader advice within investor relations, among other areas. We want to extend our gratitude to Norden CEF for serving as our Certified Adviser since the Nasdaq First North Growth Market IPO in 2020.
Any inquiries regarding this notice should be directed to:
Monsenso
CEO
Thomas Lethenborg
Tel. +45 21 29 88 27
E-mail: lethenborg@monsenso.com
Certified Adviser
Norden CEF A/S
E-mail: jn@nordencef.dk
About Monsenso
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit www.monsenso.com
Attachments
- Download announcement as PDF.pdf
© Ritzau Denmark, source
